Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Drug Delivery

Read more breaking news


News in brief

Biocon introduces insulin pen to Indian market


Biocon has begun selling a reusable insulin pen, based on Haselmeier technology, to patients in India.

INSUPen is being used to deliver two Biocon insulin products: Basalog, a long-lasting formulation; and Insugen, a recombinant human form. By delivering the products using the i-pen technology from Haselmeier Biocon hopes to ensure reliable and accurate dosing while increasing convenience.


Rakesh Bamzai, president, marketing at Biocon, said: “I am confident that INSUPen will be a delight for patients and a value enhancer for all stakeholders.” The i-pen includes dose correction to avoid errors and other features designed to ease self-administration by patients.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...